85 related articles for article (PubMed ID: 2053856)
41. [A study on the concentration of eosinophil cationic protein in chronic sinusitis].
Haruna S; Yoshikawa M; Iida M; Ohtori N; Shimada C; Ozawa M; Moriyama H
Nihon Jibiinkoka Gakkai Kaiho; 1999 Sep; 102(9):1015-21. PubMed ID: 10554553
[TBL] [Abstract][Full Text] [Related]
42. Adhesive explant culture of allergic nasal mucosa: effect of emedastine difumarate, an anti-allergic drug.
Okubo K; Pawankar R; Gotoh M; Yagi T
Jpn J Pharmacol; 1999 Mar; 79(3):351-7. PubMed ID: 10230864
[TBL] [Abstract][Full Text] [Related]
43. Activated and non-activated eosinophils in patients with chronic rhinosinusitis.
Appenroth E; Gunkel AR; Müller H; Völklein C; Schrott-Fischer A
Acta Otolaryngol; 1998 Mar; 118(2):240-2. PubMed ID: 9583793
[TBL] [Abstract][Full Text] [Related]
44. Interleukin-5 gene expression in nasal mucosa and changes in amount of interleukin-5 in nasal lavage fluid after antigen challenge.
Terada N; Konno A; Fukuda S; Yamashita T; Shirotori K; Okamoto Y; Ishikawa K; Togawa K
Acta Otolaryngol; 1994 Mar; 114(2):203-8. PubMed ID: 8203203
[TBL] [Abstract][Full Text] [Related]
45. Allergen-induced increase of eosinophil cationic protein in nasal lavage fluid: effect of the glucocorticoid budesonide.
Bisgaard H; Grønborg H; Mygind N; Dahl R; Lindqvist N; Venge P
J Allergy Clin Immunol; 1990 May; 85(5):891-5. PubMed ID: 2185293
[TBL] [Abstract][Full Text] [Related]
46. Increased expression of surface activation markers on neutrophils following migration into the nasal lumen.
Kinhult J; Egesten A; Benson M; Uddman R; Cardell LO
Clin Exp Allergy; 2003 Aug; 33(8):1141-6. PubMed ID: 12911790
[TBL] [Abstract][Full Text] [Related]
47. Inflammatory mechanisms underlying potentiation of effects of inhaled aeroallergens in response to nitrogen dioxide in allergic airways disease.
Krishna MT; Holgate ST
Clin Exp Allergy; 1999 Feb; 29(2):150-4. PubMed ID: 10051716
[No Abstract] [Full Text] [Related]
48. Late phase response in nasal mucosa closely correlated with immediate phase reaction and hyperreactivity to histamine.
Terada N; Hamano N; Hohki G; Konno A; Shirotori K; Togawa K
Acta Otolaryngol; 1998 Jun; 118(3):392-7. PubMed ID: 9655215
[TBL] [Abstract][Full Text] [Related]
49. [Nasal allergy and leukotriene. 2. Kinetics of peptide leukotrienes and inflammatory cells in nasal lavage fluid after antigen challenge].
Terada N; Ando H; Ito E; Sugiyama T; Yoshino Y; Togawa K; Konno A; Terada Y
Nihon Jibiinkoka Gakkai Kaiho; 1989 Sep; 92(9):1337-44. PubMed ID: 2585202
[TBL] [Abstract][Full Text] [Related]
50. Eosinophil influx to the nasal airway after local, low-level LPS challenge in humans.
Peden DB; Tucker K; Murphy P; Newlin-Clapp L; Boehlecke B; Hazucha M; Bromberg P; Reed W
J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 1):388-94. PubMed ID: 10452761
[TBL] [Abstract][Full Text] [Related]
51. Immunoglobulin as an eosinophil degranulation factor: change in immunoglobulin level in nasal lavage fluid after antigen challenge.
Terada N; Terada Y; Shirotori K; Ishikawa K; Togawa K; Konno A
Acta Otolaryngol; 1996 Nov; 116(6):863-7. PubMed ID: 8973723
[TBL] [Abstract][Full Text] [Related]
52. Epithelial cells in nasal fluids from patients with allergic rhinitis: how do they relate to epidermal growth factor, eosinophils and eosinophil cationic protein?
Benson M; Uddman R; Cardell LO
Acta Otolaryngol; 2002 Mar; 122(2):202-5. PubMed ID: 11936914
[TBL] [Abstract][Full Text] [Related]
53. Complement activation in the nasal mucosa following nasal ragweed-allergen challenge.
Mezei G; Varga L; Veres A; Füst G; Cserháti E
Pediatr Allergy Immunol; 2001 Aug; 12(4):201-7. PubMed ID: 11555317
[TBL] [Abstract][Full Text] [Related]
54. Preferential infiltration by activated eosinophils in allergic sinusitis.
Ogata N; Masuyama K; Yoshida M; Samejima Y; Eura M; Ishikawa T
Auris Nasus Larynx; 1997 Jul; 24(3):279-87. PubMed ID: 9251857
[TBL] [Abstract][Full Text] [Related]
55. Upper airway inflammation in waste handlers exposed to bioaerosols.
Heldal KK; Halstensen AS; Thorn J; Djupesland P; Wouters I; Eduard W; Halstensen TS
Occup Environ Med; 2003 Jun; 60(6):444-50. PubMed ID: 12771397
[TBL] [Abstract][Full Text] [Related]
56. [Determination of nasal airway resistance and its clinical application. 2. Relationship between nasal mucosa and skin reaction in nasal allergy].
Hasegawa M
Nihon Jibiinkoka Gakkai Kaiho; 1973 May; 76(5):669-74. PubMed ID: 4737575
[No Abstract] [Full Text] [Related]
57. Unilateral nasal allergic reactions increase bilateral sinus eosinophil infiltration.
Baroody FM; Detineo M; Naclerio RM
J Appl Physiol (1985); 2013 Nov; 115(9):1262-7. PubMed ID: 23970539
[TBL] [Abstract][Full Text] [Related]
58. Cell and cytokine profile in nasal secretions in cystic fibrosis.
Bergoin C; Gosset P; Lamblin C; Bolard F; Turck D; Tonnel AB; Wallaert B
J Cyst Fibros; 2002 Sep; 1(3):110-5. PubMed ID: 15463816
[TBL] [Abstract][Full Text] [Related]
59. Biochemical properties of eosinophils and their preferential accumulation mechanism in nasal allergy.
Terada N; Konno A; Togawa K
J Allergy Clin Immunol; 1994 Sep; 94(3 Pt 2):629-42. PubMed ID: 8083472
[TBL] [Abstract][Full Text] [Related]
60. Monoclonal antibody EG2 does not provide reliable immunohistochemical discrimination between resting and activated eosinophils.
Jahnsen FL; Brandtzaeg P; Halstensen TS
J Immunol Methods; 1994 Sep; 175(1):23-36. PubMed ID: 7930638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
